- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03394872
Impact of Draining Significant Effusion on Gas Exchange and Lung Mechanics in Patient Under Mechanical Ventilation
January 8, 2018 updated by: Begum Ergan, Dokuz Eylul University
Patients with acute respiratory failure (ARF) who were receiving mechanical ventilator support, had significant pleural effusion (both transudates and exudates) and drainage plan were evaluated.
Decision to drain, timing and duration of drainage were made by primary physician according to the intensive care unit (ICU) protocols.The estimated amount of effusion (mL) was calculated as the maximum pleura-lung distance (mm) x 20 and significant effusion is accepted as ≥ 800 mL according to thoracic ultrasonography (USG) performed by the intensivist.
The amount of effusion drained, mechanical ventilator parameters, arterial blood gas results and hemodynamic data were recorded before, at the 1st hour and at the end of drainage up to 30 days after drainage.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
27
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Critical care patients on mechanical ventilation due to acute respiratory failure and have significant pleural effusion who had drainage plan according to İCU protocols decided by primary physician were enrolled for the study
Description
Inclusion Criteria:
- Patients on mechanical ventilation due to acute respiratory failure
- Estimated effusion > 800 ml according to USG
- Have drainage plan according to ICU protocols decided by primary physician
Exclusion Criteria:
- Have absolute drainage indication (empyema, hemothorax or chylothorax)
- predicted duration of mechanical ventilation less than 72 hours
- contraindications to drainage,
- underlying disease, which prevents lung expansion (chest deformity, central atelectasis)
- malignant effusions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Drainage group
Patients under mechanical ventilator support due to acute respiratory failure who had significant pleural effusion and drainage plan according to the intensive Care Unit (ICU) protocols decided by primary physician
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between estimated and drained effusion volume
Time Frame: 1- Estimated effusion volume just before the drainage (by ultrasonography calculated as described in brief summary) 2- Drained effusion volume just after the drainage is terminated up to 30 days after procedure.
|
Volume of the effusion estimated and drained was recorded (mL)
|
1- Estimated effusion volume just before the drainage (by ultrasonography calculated as described in brief summary) 2- Drained effusion volume just after the drainage is terminated up to 30 days after procedure.
|
Change in Lung mechanics
Time Frame: 1- Dynamic Compliance just before the drainage 2- Dynamic Compliance just after the drainage is terminated up to 30 days after procedure
|
Dynamic Compliance (mL/cmH2O)
|
1- Dynamic Compliance just before the drainage 2- Dynamic Compliance just after the drainage is terminated up to 30 days after procedure
|
Change in Oxygenation
Time Frame: 1- PaO2/FiO2 just before the drainage 2- PaO2/FiO2 just after the drainage is terminated up to 30 days after procedure
|
PaO2/FiO2 (fraction of inspired oxygen)
|
1- PaO2/FiO2 just before the drainage 2- PaO2/FiO2 just after the drainage is terminated up to 30 days after procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Barış Yılmaz, MD, Fellow of Critical Care in Department of Pulmonary and Critical Care Medicine in Dokuz Eylül University
- Study Chair: Tuğçe Yılmaz, MD, Fellow of Critical Care in Department of Neurology and Critical Care Medicine in Dokuz Eylül University
- Principal Investigator: Begum Ergan, MD, Staff in Department of Pulmonary and Critical Care Medicine in Dokuz Eylül University
- Study Director: Necati Gokmen, MD, Staff in Department of Anesthesiology and Critical Care Medicine in Dokuz Eylül University
- Study Chair: Kutlay Aydin, MD, Fellow of Critical Care in Department of Anesthsiology and Critical Care Medicine in Dokuz Eylül University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2016
Primary Completion (Actual)
August 30, 2017
Study Completion (Actual)
August 30, 2017
Study Registration Dates
First Submitted
December 19, 2017
First Submitted That Met QC Criteria
January 8, 2018
First Posted (Actual)
January 9, 2018
Study Record Updates
Last Update Posted (Actual)
January 9, 2018
Last Update Submitted That Met QC Criteria
January 8, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2496-GOA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ultrasonography
-
Yale UniversityCompletedUltrasonographyUnited States
-
Peking Union Medical College HospitalNot yet recruitingNeuraxial Ultrasonography
-
Poitiers University HospitalCompletedUltrasonography | ObstetricsFrance
-
Università degli Studi di BresciaCompletedUltrasonography, PrenatalItaly
-
Centre Hospitalier Saint Joseph Saint Luc de LyonUnknownUltrasonography | DiaphragmFrance
-
Assuta Medical CenterUnknown
-
Rigshospitalet, DenmarkCompletedUltrasonography Skills
-
University Tunis El ManarCompleted
-
University of MichiganCompletedUltrasonographyUnited States
Clinical Trials on Drainage of the pleural effusion
-
Wuhan Union Hospital, ChinaCompletedPleural Diseases
-
Wuhan Union Hospital, ChinaCompleted
-
Universidade Nova de LisboaFundação para a Ciência e a Tecnologia; Hospital Cuf DescobertasRecruitingLung Cancer | MalignancyPortugal
-
Sohag UniversityCompleted
-
Nova Scotia Health AuthorityCompletedPneumothorax | AtelectasisCanada
-
Chang Gung Memorial HospitalEnrolling by invitation
-
E-DA HospitalUnknown
-
Kerckhoff KlinikCompleted
-
University Hospital, Clermont-FerrandCompletedPneumothorax | Hemothorax | Pleural EffusionFrance
-
University of ViennaRecruiting